Clinical Trial Update: Combined N-of-1 Trials Mexiletine vs Placebo in Patients With Non-Dystrophic Myotonia (NDM) [Phase 2]

View source ↗

Summary

A Phase 2 trial using combined N-of-1 designs to compare mexiletine against placebo in patients with non-dystrophic myotonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-dystrophic Myotonia

Drugs mentioned

• Mexiletine (Mexiletine)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Non Dystrophic Myotonia | Phase 2 | Status: COMPLETED